A hypothesis consistent with our results is that individuals with autism should carry SVs in binding sites for SRSF9 and therefore dysregulation of SRSF9-ADAR2-directed RNA-editing, which is supported by reports of decreased editing in post-mortem brain tissue in those with ASD compared to controls (Tran et al., 2019). This evidence concerns the gene SRSF9 and autism.